The present invention relates to an antibody that specifically binds to epidermal growth factor receptor variant III (EGFRvIII), a nucleic acid encoding the antibody, a vector and a host cell comprising the nucleic acid, a method for producing the antibody, and a pharmaceutical composition for treating cancer or tumors, comprising the antibody as an active ingredient.